Neotigason (Acitretin)

Acitretin, the active ingredient in Neotigason, is a retinoid presented as an oral formulation for oral use. It is employed in the management of severe psoriasis and related keratinization disorders in adult patients.

GNH USA supplies Neotigason as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Neotigason is a retinoid indicated for severe forms of psoriasis and related skin conditions. - Severe plaque psoriasis: reduces scaling, erythema and plaque thickness. - Psoriatic erythroderma: helps normalize epidermal turnover and improves skin appearance. - Generalized pustular psoriasis: controls acute pustular flares and promotes lesion clearance.

Acitretin may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dry skin and mucous membranes: dryness of lips, eyes and nasal passages. - Cheilitis: cracking and inflammation of the lips. - Elevated triglycerides: increase in blood lipid levels. - Headache: mild to moderate intensity. - Nausea: occasional gastrointestinal upset. - Hair thinning: temporary loss of scalp hair.

Serious or Rare Side Effects: - Hepatotoxicity: liver enzyme elevation or liver injury. - Severe hyperlipidemia: marked increase in cholesterol or triglycerides. - Depression or mood changes: potential psychiatric effects. - Bone abnormalities: premature epiphyseal closure in children. - Pseudotumor cerebri: increased intracranial pressure. - Severe cutaneous reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before initiating therapy, several safety considerations are required. - Teratogenicity: avoid use in pregnancy and discontinue at least 3 years before conception. - Liver function: monitor hepatic enzymes regularly during treatment. - Lipid profile: assess serum triglycerides and cholesterol before and during therapy. - Bone health: avoid in patients with active bone disease or severe skeletal growth disorders. - Concomitant vitamin A: do not combine with other vitamin A derivatives to prevent toxicity. Store at ambient temperature below 25°C: keep in original container, protect from moisture and direct sunlight.

Acitretin can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Tetracyclines: increased risk of pseudotumor cerebri. - Vitamin A supplements: additive retinoid toxicity. - Systemic methotrexate: heightened hepatic injury risk. - Warfarin: possible alteration of anticoagulant effect. - Oral contraceptives: reduced hormonal efficacy, raising teratogenic risk.

Moderate Interactions (Monitor Closely): - Statins: potential for combined lipid abnormalities and liver stress. - Glucocorticoids: additive effects on lipid metabolism. - Enzyme‑inducing antiepileptics: may lower acitretin plasma concentrations.